siRNA Targeting of Thymidylate Synthase, Thymidine Kinase 1 and Thymidine Kinase 2 as an Anticancer Therapy: A Combinatorial RNAi Approach

Leonardo M.R. Ferreira, Cancer metabolism: the Warburg effect today. Experimental and Molecular Pathology. ,vol. 89, pp. 372- 380 ,(2010) , 10.1016/J.YEXMP.2010.08.006

Stephen J. Ralph, Sara Rodríguez-Enríquez, Jiri Neuzil, Emma Saavedra, Rafael Moreno-Sánchez, The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapy Molecular Aspects of Medicine. ,vol. 31, pp. 145- 170 ,(2010) , 10.1016/J.MAM.2010.02.008

Birgitte Munch-Petersen, Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes Molecular and Cellular Biochemistry. ,vol. 64, pp. 173- 185 ,(1984) , 10.1007/BF00224774

B. Munch-Petersen, L. Cloos, H.K. Jensen, G. Tyrsted, Human thymidine kinase 1. Regulation in normal and malignant cells Advances in Enzyme Regulation. ,vol. 35, pp. 69- 89 ,(1995) , 10.1016/0065-2571(94)00014-T

Xu, Serum thymidine kinase 1 reflects the progression of pre-malignant and malignant tumors during therapy. Molecular Medicine Reports. ,vol. 1, pp. 705- 711 ,(2008) , 10.3892/MMR_00000017

Yan Chen, Mingang Ying, YanSong Chen, Minhua Hu, Yingying Lin, Dedong Chen, Xiaoli Li, Ming Zhang, Xia Yun, Ji Zhou, Ellen He, Sven Skog, Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings International Journal of Clinical Oncology. ,vol. 15, pp. 359- 368 ,(2010) , 10.1007/S10147-010-0067-4

Zhaohui Wang, Donald D. Rao, Neil Senzer, John Nemunaitis, RNA interference and cancer therapy. Pharmaceutical Research. ,vol. 28, pp. 2983- 2995 ,(2011) , 10.1007/S11095-011-0604-5

William Lewis, Marinos C. Dalakas, Mitochondrial toxicity of antiviral drugs. Nature Medicine. ,vol. 1, pp. 417- 422 ,(1995) , 10.1038/NM0595-417

Edward Chu, Marc A. Callender, Michael P. Farrell, John C. Schmitz, Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemotherapy and Pharmacology. ,vol. 52, pp. 80- 89 ,(2003) , 10.1007/S00280-003-0625-9

Jason D. Fowler, Jessica A. Brown, Kenneth A. Johnson, Zucai Suo, Kinetic Investigation of the Inhibitory Effect of Gemcitabine on DNA Polymerization Catalyzed by Human Mitochondrial DNA Polymerase Journal of Biological Chemistry. ,vol. 283, pp. 15339- 15348 ,(2008) , 10.1074/JBC.M800310200